deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT00720694

Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome (ESWT)

Placebo Controlled Study to Investigate the Effectiveness and Safety of Extracorporeal Shock Wave Therapy in Unsuccessful Conservatively Treated Subject Suffering From Painful Heel Syndrome

Sponsor: Storz Medical AG

Updated 8 times since 2017 Last updated: Feb 15, 2018 Started: Jun 30, 2006 Primary completion: May 31, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Plantar Fasciitis, this trial is completed. The trial is conducted by Storz Medical AG and has accumulated 8 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotWithheld~Feb 2017 – ~Mar 2018 · 13 months · monthly snapshotWithheld~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotCompleted~Jun 2018 – ~Feb 2020 · 20 months · monthly snapshotCompleted~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 20 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Feb 2020 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jun 2018 — Feb 2020 [monthly]

    Completed PHASE3

Show 3 earlier versions
  1. Mar 2018 — Jun 2018 [monthly]

    Completed PHASE3

    Status: WithheldCompleted · Phase: NAPHASE3

  2. Feb 2017 — Mar 2018 [monthly]

    Withheld NA

  3. Jan 2017 — Feb 2017 [monthly]

    Withheld NA

    First recorded

Jun 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Storz Medical AG
Data source: Storz Medical AG

For direct contact, visit the study record on ClinicalTrials.gov .